Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.
Sign Up to like & getrecommendations! Published in 2023 at "Population health management"
DOI: 10.1089/pop.2022.0227
Abstract: Abstract This study investigated the clinical and economic impact of anti-obesity medications (AOMs; orlistat, liraglutide, phentermine/topiramate extended-release [ER], naltrexone ER/bupropion ER) among United States Veterans with obesity participating in Motivating Overweight/Obese Veterans Everywhere! (MOVE!), a… read more here.
Keywords: program; management; anti obesity; move cohort ... See more keywords